Bariatric Surgery Shows Promise In Preventing Type 2 Diabetes
This article was originally published in The Gray Sheet
Executive Summary
At 15 years of follow-up in the Swedish Obese Subjects study, 110 bariatric surgery patients had developed type 2 diabetes versus 392 non-surgery patients in the control group, corresponding to incidence rates of 6.8 cases and 28.4 cases per 1,000 person-years, respectively.
You may also be interested in...
Cleveland Clinic’s ‘Top 10’ Picks For 2013 Include Eight Device-Related Innovations
Renowned academic medical center unveils its annual ‘top 10’ list of medical innovations it anticipates will have a major impact on patient care within the next year, including eight that are device-related.
Bariatric Surgery Bests Medical Therapy In Treating Diabetes
The findings come from two studies, including the randomized STAMPEDE trial, funded by Johnson & Johnson and the National Institutes of Health, comparing medical therapy with two forms of surgical treatment – gastric bypass or sleeve gastrectomy.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.